- Obama encourages ICE to stand down, say former border agents
- Pro-Palestinian protesters attack Israeli soccer team in Austria match
- Virginia police: 2 dead after storm at campground
- Ukrainian prime minister announces resignation
- House members question $17 billion VA request
- N.Y. Gov. Cuomo launches statewide task force to collect LGBT data
- Obama’s motorcade prevents woman in labor from crossing street to hospital
- Grijalva: Anti-trafficking law ‘line in the sand for many of us’
- Joe Biden: ‘Businesses are hiring at historic rates’
- Jeb Bush to Congress: Don’t use border crisis as excuse to delay immigration reform
Roche is challenged to prove worth of Tamiflu
Question of the Day
LONDON — A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu.
The drug has been stockpiled by dozens of governments worldwide in case of a global flu outbreak and was widely used during the 2009 swine flu pandemic.
On Monday, one of the researchers linked to the BMJ journal called for European governments to sue Roche.
"I suggest we boycott Roche's products until they publish missing Tamiflu data," wrote Peter Gotzsche, leader of the Nordic Cochrane Centre in Copenhagen. He said governments should take legal action against Roche to get the money back that was "needlessly" spent on stockpiling Tamiflu.
Last year, Tamiflu was included in a list of "essential medicines" by the World Health Organization, a list that often prompts governments or donor agencies to buy the drug. Tamiflu is used to treat both seasonal flu and new flu viruses like bird flu or swine flu.
WHO spokesman Gregory Hartl said the agency had enough proof to warrant its use for unusual influenza viruses such as bird flu.
"We do have substantive evidence it can stop or hinder progression to severe disease like pneumonia," he said.
In the U.S., the Centers for Disease Control and Prevention recommends Tamiflu as one of two medications for treating regular flu. The other is GlaxoSmithKline's Relenza. The CDC says such antivirals can shorten the duration of symptoms and reduce the risk of complications and hospitalization.
In 2009, the BMJ and researchers at the Nordic Cochrane Centre asked Roche to make all its Tamiflu data available. At the time, Cochrane Centre scientists were commissioned by Britain to evaluate flu drugs. They found no proof that Tamiflu reduced the number of complications in people with influenza.
"Despite a public promise to release [internal company reports] for each [Tamiflu] trial Roche has stonewalled," BMJ editor Fiona Godlee wrote in an editorial last month.
In a statement, Roche said it had complied with all legal requirements on publishing data and provided Mr. Gotzsche and his colleagues with 3,200 pages of information to answer their questions.
"Roche has made full clinical study data available to national health authorities according to their various requirements, so they can conduct their own analyses," the company said.
Roche said it doesn't usually release patient-level data due to legal or confidentiality constraints. It said it did not provide the requested data to the scientists because they refused to sign a confidentiality agreement.
Roche is also being investigated by the European Medicines Agency for not properly reporting side effects, including possible deaths, for 19 drugs including Tamiflu that were used in about 80,000 patients in the United States.
TWT Video Picks
The subsidies are a hit with patients who don't exist
- Hamas rejects Kerry's call for cease-fire; Fears grow others could join fight against Israel
- Obama's empty tough-talk: Gun prosecutions plummet on his watch
- Algerian plane diverted due to storms, second aircraft: 116 missing
- Obama dispatches researchers to border to check on National Guard
- Whistleblowers flood VA with lawsuits despite apology
- 'We're coming for you, Barack Obama': Top U.S. official discloses threat from ISIL terrorists
- Conservative groups decry Democrats' 'war on women' tactic
- Obama says public not familiar enough with issues
- Astronaut shares 'saddest photo' from space: Bombs bursting over Israel, Gaza
- NAPOLITANO: What if our democracy is a fraud?
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq